The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer

The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer

Background and purpose: With currently available techniques, the prediction of pathologic complete response after neoadjuvant chemoradiotherapy is insufficient. The tumor-stroma ratio (TSR) has proven to be a predictor of survival for several types of cancer, including esophageal. The aim of this st...

Full description

Bibliographic Details
Main Authors: G.W. van Pelt, J.A. Krol, I.M. Lips, F.P. Peters, D. van Klaveren, J.J. Boonstra, W.O. de Steur, R.A.E.M. Tollenaar, A. Farina Sarasqueta, W.E. Mesker, M. Slingerland
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Clinical and Translational Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630819301107

Internet

http://www.sciencedirect.com/science/article/pii/S2405630819301107

Similar Items